Table 1 Clinical and pathologic characteristics of patients in the pre-processed TCGA and GEO HCC datasets
Characteristic | Training Set (n = 171) | Validation Set (n = 171) | P value* | ICGC HCC dataset (n = 212) | GSE15654 dataset (n = 216) | |
|---|---|---|---|---|---|---|
Age (years) | ≤60 | 81 | 84 | 0.828 | 43 | – |
> 60 | 90 | 87 | 169 | – | ||
Survival Status | Living | 109 | 110 | 1 | 176 | 150 |
Dead | 62 | 61 | 36 | 66 | ||
Sex | Female | 55 | 54 | 1 | 50 | – |
Male | 116 | 117 | 162 | – | ||
Grade | G1 | 24 | 29 | 0.513 | – | – |
G2 | 82 | 79 | – | – | ||
G3 | 59 | 52 | – | – | ||
G4 | 4 | 8 | – | – | ||
Pathologic T stage | T1 | 79 | 89 | 0.028 | – | – |
T2 | 54 | 30 | – | – | ||
T3 | 43 | 41 | – | – | ||
T4 | 4 | 9 | – | – | ||
Pathologic N stage | N0 | 120 | 119 | 0.934 | – | – |
N1/Nx | 50 | 52 | – | – | ||
Pathologic M stage | M0 | 128 | 116 | 0.188 | – | – |
M1/Mx | 43 | 55 | – | – | ||
Tumor Stage | Stage I | 78 | 83 | 0.011 | 33 | – |
Stage II | 50 | 27 | 102 | – | ||
Stage III | 34 | 46 | 61 | – | ||
Stage IV | 1 | 2 | 16 | – | ||